SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Pancreatic Adenocarcinoma Metastatic|BRCA1 Mutation|BRCA2 Mutation|Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Pancreatic Cancer|Metastatic Pancreatic Cancer|Metastatic Pancreatic Ductal Adenocarcinoma|Breast Cancer Metastatic|Breast Cancer Stage IV|Pancreatic Cancer Stage IV|HER2-negative Breast Cancer|HER2 Negative Breast Carcinoma|Adenocarcinoma of the Breast|PALB2 Gene Mutation
Interventions: DRUG: Melphalan|DRUG: BCNU|DRUG: Vitamin B12B|DRUG: Vitamin C|DRUG: Ethanol|DEVICE: Autologous Hematopoietic Stem Cells
Sponsor: General Oncology, Inc.
Collaborators: Myriad Genetics, Inc.